Clinical Trials for Breast Cancer
Should you or shouldn't you? Weighing the pros and cons of joining a breast cancer clinical trial.
By Gina Shaw
Reviewed By Charlotte Grayson
Only about 3% of women with breast cancer take part in clinical trials, according to Y-ME, the national breast cancer organization.
This low level of clinical research participation may be stalling treatment progress. The fewer women who join clinical trials, the longer it takes to get data about whether a new treatment is an improvement over existing ones.
Should you join a breast cancer clinical trial? If you do, how can you choose the best one for you?
"Patients should be biased toward clinical trials," says Clifford Hudis, MD, Chief of the Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center in New York. "If you [are seen at a medical] center and they have a trial for which you're appropriate, you should seriously consider it."
What are the advantages of participating in a clinical trial?